To buy shares in Biopharma Credit Plc you will need a FCA regulated UK stock broker like AJ Bell, Hargreaves Lansdown or interactive investor where it currently costs 65.5p to buy one share in Biopharma Credit Plc (as of 17:01 22-Aug-2025). Which is a change of 0.8p or -1.21% from the last closing price of 66.3p.
How To Buy Biopharma Credit Plc Shares
It may seem complicated to buy shares for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Biopharma Credit Plc:
- Pick a stock broker (jump down to compare the best brokers for buying Biopharma Credit Plc shares)
- Deposit funds (via bank transfer or debit card)
- Search for the company share symbol: (LON:BPCP)
- Choose the number of shares you want to buy (1 share currently costs 65.5p)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the shares cheaper if you think the price will go down)
- Track the performance of your Biopharma Credit Plc shares in your account (this will show your profit and loss)
- Biopharma Credit Plc is currently worth £1,016,305,000 based on the last closing price of 66.3p with 179,601 shares traded.
- The most recent Biopharma Credit Plc daily high has been 68p and daily low 65.5p.
- The Biopharma Credit Plc share price 52 week high has been 74.03p and the 52 week low 60.4p.
Compare Brokers For Buying Biopharma Credit Plc Stock
You can buy these UK shares in a General investment account, or a stocks and shares ISA where your profits are tax-free. Or if you are investing for your retirement, you can buy them in a SIPP where profits are also tax-free but you cannot access the money until you reach 55.
| Share Dealing Platform | Share Dealing Account Fee | Share Dealing Commission | GIA | ISA | SIPP | LISA | Customer Reviews | More Info |
|---|---|---|---|---|---|---|---|---|
 | £24 – £0 Quarterly | £0 | ✔️ | ✔️ | ✔️ | ❌ | (Based on 678 reviews)
| Visit Platform Capital at risk |
 | £4.99 Monthly | £3.99 | ✔️ | ✔️ | ✔️ | ❌ | (Based on 1,119 reviews)
| Visit Platform Capital at risk |
 | £0 | £3 | ✔️ | ✔️ | ✔️ | ❌ | (Based on 934 reviews)
| Visit Platform Capital at risk |
 | 0.25% – 0% | £5 – £3.50 | ✔️ | ✔️ | ✔️ | ✔️ | (Based on 1,094 reviews)
| Visit Platform Capital at risk |
 | 0.45% – 0% | £11.95 – £5.95 | ✔️ | ✔️ | ✔️ | ✔️ | (Based on 1,758 reviews)
| Visit Platform Capital at risk |
 | 0.4% – 0.08% | £1 – 0.08% | ✔️ | ✔️ | ✔️ | ❌ | (Based on 73 reviews)
| Visit Platform Capital at risk |
Is Now A Good Time To Buy Biopharma Credit Plc Stock?
For expert analysis join Good Money Guide Premium.
- Biopharma Credit Plc’s EPS (earnings per share) are n/a. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Biopharma Credit Plc’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Biopharma Credit Plc share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.